These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27840228)

  • 1. Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry.
    Bivehed E; Strömvall R; Bergquist J; Bakalkin G; Andersson M
    Peptides; 2017 Jan; 87():20-27. PubMed ID: 27840228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALDI imaging mass spectrometry of neuropeptides in Parkinson's disease.
    Hanrieder J; Ljungdahl A; Andersson M
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22370902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.
    Hanrieder J; Ljungdahl A; Fälth M; Mammo SE; Bergquist J; Andersson M
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.009308. PubMed ID: 21737418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease.
    Ljungdahl A; Hanrieder J; Fälth M; Bergquist J; Andersson M
    PLoS One; 2011; 6(9):e25653. PubMed ID: 21984936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus.
    Sandin J; Tan-No K; Kasakov L; Nylander I; Winter A; Silberring J; Terenius L
    Peptides; 1997; 18(7):949-56. PubMed ID: 9357051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin converting enzyme with unusual specificity from rat brain.
    Devi L; Goldstein A
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1892-6. PubMed ID: 6143321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of leumorphin (dynorphin B-29) to dynorphin B and dynorphin B-14 by thiol protease activity.
    Devi L; Goldstein A
    J Neurochem; 1986 Jul; 47(1):154-7. PubMed ID: 2872272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal methylation of truncated neuropeptides: an enzyme-assisted extraction artifact involving methanol.
    Stemmler EA; Barton EE; Esonu OK; Polasky DA; Onderko LL; Bergeron AB; Christie AE; Dickinson PS
    Peptides; 2013 Aug; 46():108-25. PubMed ID: 23714174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of neuropeptide processing endopeptidases in adult rat brain.
    Berman YL; Rattan AK; Carr K; Devi L
    Biochimie; 1994; 76(3-4):245-50. PubMed ID: 7819330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic conversion of dynorphin A in the rat brain is affected by administration of nandrolone decanoate.
    Magnusson K; Hallberg M; Bergquist J; Nyberg F
    Peptides; 2007 Apr; 28(4):851-8. PubMed ID: 17240479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immunoreactive dynorphin B and beta-endorphin in human plasma.
    Silberring J; Li YM; Terenius L; Nylander I
    Peptides; 1998; 19(8):1329-37. PubMed ID: 9809646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide processing by single-step cleavage: conversion of leumorphin (dynorphin B-29) to dynorphin B.
    Devi L; Goldstein A
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1168-76. PubMed ID: 2862869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a secreted arginine-specific dibasic cleaving enzyme from EL-4 cells.
    Csuhai E; Safavi A; Hersh LB
    Biochemistry; 1995 Sep; 34(38):12411-9. PubMed ID: 7547986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test.
    Tan-No K; Taira A; Sakurada T; Inoue M; Sakurada S; Tadano T; Sato T; Sakurada C; Nylander I; Silberring J; Terenius L; Kisara K
    Eur J Pharmacol; 1996 Oct; 314(1-2):61-7. PubMed ID: 8957219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.
    Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sakurada S; Bakalkin G; Terenius L; Tadano T
    Int Rev Neurobiol; 2009; 85():191-205. PubMed ID: 19607971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat.
    Ajimi J; Yoshikawa M; Takahashi S; Miura M; Tsukamoto H; Kawaguchi M; Kobayashi H; Suzuki T
    J Anesth; 2015 Feb; 29(1):65-77. PubMed ID: 24943455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a dynorphin-processing endopeptidase.
    Berman YL; Juliano L; Devi LA
    J Biol Chem; 1995 Oct; 270(40):23845-50. PubMed ID: 7559562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of specificity and inhibition of human cerebrospinal fluid dynorphin converting enzyme.
    Demuth HU; Nyberg F
    J Enzyme Inhib; 1991; 4(4):299-306. PubMed ID: 1688305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of dynorphins by peptidases of pulmonary artery endothelial cells.
    Zharikova A; Zharikov S; Block ER; Prokai L
    Endothelium; 2002; 9(1):37-44. PubMed ID: 12901359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of dynorphin-(1-13) and dynorphin-(1-17) by the neuroblastoma cell membrane. Evidence for the involvement of a cysteine protease.
    Satoh M; Yokosawa H; Ishii S
    Biochem Biophys Res Commun; 1986 Oct; 140(1):335-41. PubMed ID: 2877660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.